JulianB.A., QuarlesL.D., NiemannK.M.W.Musculoskeletal complications after renal transplantation: Pathogenesis and treatment. Am J Kidney Dis1992; 2: 99–120.
2.
Conference report. Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med1993; 94: 646–50.
3.
JulianB.A., LaskowD.A., DubovskyJ.Rapid loss of vertebral mineral density after transplantation. N Engl J Med1991; 325: 544–50.
4.
WolpawT., DealC.L., Fleming-BrooksS.Factors influencing vertebral bone density after renal transplantation. Transplantation1994; 58: 1186–9.
5.
AlmondM.K., KwanJ.T., EvansK.Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron1994; 66: 52–7.
6.
AraldiA., TarantinoA., MontagninoG.Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients. A prospective study. Transplantation1997; 63: 380–6.
7.
ElliA., RivoltaR., Quarto di PaoloF.A randomized trial of deflazacort versus 6-methylprednisolone in renal transplantation-immunosuppressive activity and side effects. Transplantation1993; 55: 209–11.
8.
GennariC., ImbimboB.Effects of prednisone and deflazacort on vertebral bone mass. Calcif Tissue Int1985; 37: 592–3.
9.
LoertscherR., ThielG., HarderF.Persistent elevation of alkaline phosphatases in cyclosporine-treated renal transplant recipients. Transplantation1983; 36: 115.
10.
EttingerB., GenanatH.K., CannC.E.Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med1985; 102: 319–24.
11.
GallagherJ.C., RiggsB.L.Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate. Metabolism1990; (suppl 1) S30–4.
12.
AliciaJ.F., VaswaniA., YehJkCalcitriol in the treatment of post-menopausal osteoporosis. Am J Med1988; 84: 4018.
13.
OttS.M., ChesnutC.H.Calcitriol treatment is not effective in post-menopausal osteoporosis. Ann Intern Med1989; 110: 267–74.
14.
SambrookP., BirminghamJ., KellyP.Prevention of corticoid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med1993; 328: 1747–52.
15.
OvergaardK., HansenM.A., JensenS.B.Effect of salcalcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ1992; 305: 556–61.
16.
BohningW., RingeJ.D.Intranasal calcitonin in steroid dependent chronic obstructive pulmonary disease (COPD to prevent bone mass decrease: a one year controlled and randomized trial1990, 3rd Int Symp Osteoporosis.
17.
AdachiJ, BensenW, BrownJ.Intermittent etidronate therapy to prevent corticosteroid induced osteoporosis. N Engl J Med1997; 337: 382–421.
18.
BlackD.M., CummingsS.R., KarpfD.B.Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet1996; 348: 1535–41.
19.
ThiebaudD., KriegbaumH., HussH.Intravenous injections of ibandronate in the treatment of post-menopausal osteoporosis. Osteoporosis1996; 1: 321–5.
20.
SlatopolskyE., MartinK.Glucocorticoids and renal transplant osteonecrosis. Adv Exp Med Biol1984; 171: 353–9.
21.
HarringtonK.D., MurrayW.R., KountzS.L.Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am1971; 53: 203–15.
22.
PieridesA.M., SimpsonW., StainsbyD.Avascular necrosis of bone following renal transplantation. Q J Med1975; 44: 459–80.
23.
VincentiF., HattnerR., AmendW.J.Jr.Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. J Am Med Assoc1981; 245: 930–3.
24.
ParfreyPs, FargeD., ParfreyN.A.The decreased incidence of aseptic necrosis in renal transplant recipients. A case control study. Transplantation1986; 41: 182–7.
25.
ElmstedtE.Avascular bone necrosis in the renal transplant patient. Clin Orthop1981; 158: 149–57.
26.
WarnerJ.J.P., PhilipJ.H., BrodsleyG.L.Studies of nontraumatic osteonecrosis. Clin Orthop1987; 225: 104–27.
27.
BrazilM., LindererR.J., DickhansM.J.Aseptic hip necrosis after renal transplantation. Arch Surg1986; 121: 803–5.
